Concord Biotech moves up on incorporating wholly owned subsidiary

23 Jul 2025 Evaluate

Concord Biotech is currently trading at Rs. 1937.10, up by 39.80 points or 2.10% from its previous closing of Rs. 1897.30 on the BSE.

The scrip opened at Rs. 1892.00 and has touched a high and low of Rs. 1945.00 and Rs. 1869.05 respectively. So far 9208 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 2658.00 on 20-Sep-2024 and a 52 week low of Rs. 1370.05 on 07-May-2025.\

Last one week high and low of the scrip stood at Rs. 1945.00 and Rs. 1835.05 respectively. The current market cap of the company is Rs. 20297.64 crore.

The promoters holding in the company stood at 44.08%, while Institutions and Non-Institutions held 17.95% and 37.96% respectively.

Concord Biotech has incorporated wholly owned subsidiary company namely ‘Concord Lifegen’. The newly incorporated entity belongs to Biopharmaceutical Industry. The wholly owned subsidiary company is incorporated to manage the marketing, sales, and distribution of pharmaceutical products. Its primary objectives include executing targeted sales strategies, ensuring regulatory compliance across domestic and international markets, handling logistics and customer support, and maintaining transparent reporting to the holding company.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.

Concord Biotech Share Price

1404.05 1.00 (0.07%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×